-
1
-
-
84899475386
-
c-Myc-mediated epigenetic silencing of microRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma
-
Wang L, Zhang X, Jia L-T, Hu S-J, Zhao J, Yang J-D, et al. c-Myc-mediated epigenetic silencing of microRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma. Hepatology 2014;59:1850-1863.
-
(2014)
Hepatology
, vol.59
, pp. 1850-1863
-
-
Wang, L.1
Zhang, X.2
Jia, L.-T.3
Hu, S.-J.4
Zhao, J.5
Yang, J.-D.6
-
2
-
-
84873296666
-
MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?
-
Giordano S, Columbano A. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology 2013;57:840-847.
-
(2013)
Hepatology
, vol.57
, pp. 840-847
-
-
Giordano, S.1
Columbano, A.2
-
3
-
-
84857079737
-
The microcosmos of cancer
-
Lujambio A, Lowe SW. The microcosmos of cancer. Nature 2012;482:347-355.
-
(2012)
Nature
, vol.482
, pp. 347-355
-
-
Lujambio, A.1
Lowe, S.W.2
-
4
-
-
59149098054
-
MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity
-
Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y, Zhuang SM. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 2009;69:1135-1142.
-
(2009)
Cancer Res
, vol.69
, pp. 1135-1142
-
-
Su, H.1
Yang, J.R.2
Xu, T.3
Huang, J.4
Xu, L.5
Yuan, Y.6
Zhuang, S.M.7
-
5
-
-
84856466661
-
The role of EZH2 in tumour progression
-
Chang CJ, Hung MC. The role of EZH2 in tumour progression. Br J Cancer 2012;106:243-247.
-
(2012)
Br J Cancer
, vol.106
, pp. 243-247
-
-
Chang, C.J.1
Hung, M.C.2
-
6
-
-
77956222562
-
Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer
-
Sauvageau M, Sauvageau G. Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell 2010;7:299-313.
-
(2010)
Cell Stem Cell
, vol.7
, pp. 299-313
-
-
Sauvageau, M.1
Sauvageau, G.2
-
7
-
-
58149239686
-
Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer
-
Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008;322:1695-1699.
-
(2008)
Science
, vol.322
, pp. 1695-1699
-
-
Varambally, S.1
Cao, Q.2
Mani, R.S.3
Shankar, S.4
Wang, X.5
Ateeq, B.6
-
8
-
-
84875415642
-
Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: functional and therapeutic implications
-
Corvetta D, Chayka O, Gherardi S, D'Acunto CW, Cantilena S, Valli E, et al. Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: functional and therapeutic implications. J Biol Chem 2013;288:8332-8341.
-
(2013)
J Biol Chem
, vol.288
, pp. 8332-8341
-
-
Corvetta, D.1
Chayka, O.2
Gherardi, S.3
D'Acunto, C.W.4
Cantilena, S.5
Valli, E.6
-
9
-
-
7744220635
-
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
-
Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, Mandl S, et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 2004;431:1112-1117.
-
(2004)
Nature
, vol.431
, pp. 1112-1117
-
-
Shachaf, C.M.1
Kopelman, A.M.2
Arvanitis, C.3
Karlsson, A.4
Beer, S.5
Mandl, S.6
-
10
-
-
84859171807
-
MYC on the path to cancer
-
Dang CV. MYC on the path to cancer. Cell 2012;149:22-35.
-
(2012)
Cell
, vol.149
, pp. 22-35
-
-
Dang, C.V.1
-
11
-
-
65549083102
-
The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2
-
Friedman JM, Liang G, Liu CC, Wolff EM, Tsai YC, Ye W, et al. The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res 2009;69:2623-2629.
-
(2009)
Cancer Res
, vol.69
, pp. 2623-2629
-
-
Friedman, J.M.1
Liang, G.2
Liu, C.C.3
Wolff, E.M.4
Tsai, Y.C.5
Ye, W.6
|